Tylan 200

Target species Tylan 200 mg/ml Solution for Injection is indicated for use in cattle and pigs. Indications for use, specifying the target species Tylan 200 mg/ml injection is indicated in all conditions associated with bacteria sensitive to tylosin which includes organisms in the following genera: Streptococcus Campylobacter Bacillus Spirochaetes Staphylococcus Chlamydia Corynebacterium Fusiformis Clostridium Pasteurella Erysipelothrix Tylan 200 mg ml injection has been successfully used in respiratory and genito-urinary tract infections, otitis, cellulitis and secondary bacterial conditions associated with virus disease or post operative infections. Specific disease entities treated successfully with Tylan include swine dysentery, erysipelas and enzootic pneumonia in pigs, foul in the foot, mastitis and calf pneumonia in cattle. Contraindications Tylan 200 should not be given to chickens or turkeys. Do not administer to horses or other equines in which injection of tylosin may be fatal. Special warnings for each target species None. Special precautions for use (i) Special precautions for use in animals Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information. For administration by the intramuscular route only. Use different injection sites for repeat injections. The efficacy data do not support the use of tylosin for the treatment of bovine mastitis caused by Mycoplasma spp. (ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals Care should be taken to avoid accidental self-injection. If accidental self-injection occurs, seek medical attention immediately. In the event of accidental skin contact, wash thoroughly with soap and water. In case of accidental eye contact, flush the eyes with plenty of clean, running water. Wash hands after use. Tylosin may induce irritation. Macrolides, such as tylosin, may also cause hypersensitivity (allergy) following injection, inhalation, ingestion or contact with skin or eye. Hypersensitivity to tylosin may lead to cross reactions to other macrolides and vice versa. Allergic reactions to these substances may occasionally be serious and therefore direct contact should be avoided. Do not handle the product if you are allergic to ingredients in the product. If you develop symptoms following exposure, such as skin rash, you should seek medical advice and show the physician this warning. Swelling of the face, lips and eyes or difficulty in breathing are more serious symptoms and require urgent medical attention. (iii) Other precautions Blemishes may occur at the site of injection and can persist for up to 21 days following administration. Adverse reactions (frequency and seriousness) Possible adverse reactions attributed to the product when used as recommended and their frequency are: In very rare cases the following have been observed; - swelling/inflammation at the site of injection, - vulvular swelling in cattle, - oedema of the rectal mucosa, partial anal protrusion (‘rosebudding’) - erythema and pruritus in pigs. - Anaphylactic shock and death. Use during pregnancy, lactation or lay No adverse effects to tylosin have been seen in fertility, multi-generation or teratology studies. Interaction with other medicinal products and other forms of interaction None observed.
Vat Rate: 20%